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mAbstract
Background: The goal of this prospective study was to estimate the absorbed
(radiation) doses to salivary glands in radioiodine therapy of thyroid cancer under
chewing-gum stimulation using 124I positron emission tomography (PET)/computed
tomography (CT) imaging.
Methods: Duplex ultrasonography was conducted in three test persons for visual
comparison of the glandular blood flow with three different stimulation types (no
stimulation, chewing tasteless gum base, sucking on lemon slices). Ten patients
with newly diagnosed differentiated thyroid cancer received 124I PET/CT dosimetry
after thyroidectomy and prior to radioiodine therapy. Patients underwent a series
of three 124I PET/CT scans (4, 24, and ≥96 h after administration of 23 MBq 124I).
They were instructed to chew gum base (tasteless) approximately 20 min after
ingesting the 124I-containing capsule in the course of the first day. Absorbed doses
per administered 131I activity to the salivary glands were calculated and compared
with the previously published results of the lemon-juice stimulation and
non-stimulation groups.
Results: The sonograms in the three test persons showed that glandular blood
perfusion by lemon-juice stimulation was clearly increased compared with
non-stimulation or chewing of gum base. The sonogram comparison between the
chewing-gum stimulation and non-stimulation demonstrated a minor increase of
blood flow for the gum base-stimulated salivary glands. The mean ± standard deviation
of the absorbed dose per activity under chewing-gum stimulation for the submandibular
and parotid glands (within parentheses) was 0.22 ± 0.09 Gy/GBq (0.22 ± 0.08 Gy/GBq).
Compared with the absorbed doses of the non-stimulation group, 0.24 ± 0.08
Gy/GBq (0.21 ± 0.05 Gy/GBq), those of the chewing-gum stimulation group
showed no significant change (P > 0.60), but the absorbed doses of the lemon-juice
stimulation group, 0.35 ± 0.14 Gy/GBq (0.33 ± 0.09 Gy/GBq), were significantly higher
(P < 0.04) than those of the chewing-gum stimulation group.
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Conclusions: The results suggest that salivary flow induced by chewing gum base does
not cause a significant reduction of the salivary gland absorbed dose compared with
that in the non-stimulation group. The increased blood flow appears to be a decisive
factor causing the increased 131I absorbed doses in the lemon-juice stimulation group.
Keywords: Salivary gland; Thyroid carcinoma; Radioiodine therapy; Dosimetry; Iodine-124Background
Radioiodine treatment of differentiated thyroid cancer has been proven highly effective;
however, application of high 131I activity has been found to be associated with side effects.
Organs at risk in high-activity radioiodine therapies are the bone marrow and the lung
[1,2]. In addition, the parotid and submandibular glands may also be affected by high-activity
radioiodine therapies, which may cause sialadenitis and xerostomia [3]. The radioiodine
uptake in (major) salivary glands is mediated by the sodium-iodide symporter [4].
Sialadenitis appears transiently, but in particular, xerostomia can persist for an entire
lifetime and may severely affect the patient's quality of life. For more than almost 30 years,
radioprotective procedures have been proposed to mitigate damage to the salivary glands
[5]. The use of sialogogic agents such as lemon juice, sour candies, and flavoured chewing
gums is recommended [1,5]. The reasoning is based on the grounds that salivary gland
stimulation after 131I administration reduces the radiation exposure time (residence time).
Hence, radiogenic damage is thought to be reduced by increase of salivary flow.
Recent studies [6,7] by means of 131I scintigraphy supported the hypothesis. A case
report [6] measured the 131I activity within the salivary gland before and shortly after
lemon-juice stimulation. Scintigraphy images were acquired starting at 2 h after radio-
iodine administration. Single addition of lemon juice in the oral cavity produced a rapid
decrease of approximately 80% to 90% of its initial value, but the 131I activity reached a
maximum of its initial value after 10 to 30 min. In a follow-up study [7], similar results
using 123I were obtained in 23 patients with the same methodology. Thus, the authors
postulated that a repeated stimulation by lemon juice during radioiodine therapy
should reduce the radioiodine residence time and consequently also the radiogenic
damage. The reduction of the residence time of radioiodine (efflux > influx) within the
salivary glands using sialogogic agents is termed the washout effect.
Three studies attempted to verify the proposed washout effect [8-10] using different
methodologies under clinical conditions; however, none of these clinical studies could
confirm the washout effect. In particular, Nakada et al. [8] observed in a prospective
and longitudinal comparison study that an early start of sucking lemon candies (<1 h
after 131I administration) induced a significantly higher incidence of sialoadenitis and
xerostomia frequency compared with a 24-h delayed stimulation. Liu et al. [9] and our
group [10] used a dosimetry approach. The absorbed (radiation) dose is an established
quantity that is used to assess the potential for mediating the radiogenic damage. Liu
et al. estimated the absorbed doses to the salivary gland using 131I scintigraphy. They
compared the absorbed doses per administered 131I activity of four groups, who were
stimulated at different time points after radioiodine administration (1, 5, 13, and 25 h)
using vitamin C (as a substitute for lemon juice). No significant differences among the
four groups were found. The authors concluded that salivary gland stimulation with
Jentzen et al. EJNMMI Physics 2014, 1:100 Page 3 of 11
http://www.ejnmmiphys.com/content/1/1/100vitamin C caused only a minor reduction of the absorbed dose. Our group estimated
the absorbed doses using a more precise dosimetry approach than that used by Liu
et al. [9]. We applied both positron emission tomography (PET) with 124I as a diagnos-
tic equivalent to 131I scintigraphy and computed tomography (CT). The absorbed doses
of two stimulation groups, each containing ten patients, were compared. The salivary
glands of the first group were stimulated by chewing lemon slices shortly after 124I
administration, whereas the second group was not stimulated. Against prevailing
expectations, the 124I PET/CT salivary gland dosimetry yielded a significant increase of
the absorbed dose per activity of 20% to 30% for the lemon-juice stimulation group
compared with the non-stimulation group. The results of the three groups obviously
contradict the prevailing opinion. A possible mechanism for explaining their results is
the rebound effect. The sialogogic agents increase not only the salivary flow (efflux of
radioiodine) but also the blood flow (influx of radioiodine). This combination may re-
sult in a net increase of the residence time of radioiodine (efflux < influx).
The present 124I PET/CT study further explored the radioiodine uptake mechanism
of the salivary glands using another stimulation type. The aims of this prospective study
were to assess the effect of chewing-gum stimulation on the absorbed doses to the sal-
ivary glands using 124I PET/CT and to compare the results with those for the non-
stimulation and lemon-juice stimulation groups already reported [10].
Methods
Blood flow measurements
To determine the blood flow within the glandular tissue, an established methodology
was applied [11] on three healthy test persons, two males of ages 38 and 47 and one fe-
male of age 23. Duplex sonography was conducted on these three subjects using an
iU22 xMATRIX ultrasound system (Philips Healthcare, Hamburg, Germany). Initially,
the salivary glands were imaged without stimulation and thereafter stimulated by either
chewing gum base or sucking on lemon juice. The submandibular gland's sonograms
were used representatively because they allowed a better visualization with ultrasound
than the parotid glands [11]. Duplex ultrasonography was performed during sucking on
a slice of lemon. In contrast, since imaging was difficult to perform during lower jaw
movements, the images were acquired shortly after a period of 1 min of chewing-gum
stimulation. For the comparison of the different stimulation types, the sonograms of
the non-stimulated glands served as the reference standard.
Patients
Our department has routinely been conducting pre-therapy 124I PET/CT scans for high-risk
patients with differentiated thyroid cancer to perform lesion and organ-at-risk dosimetries
[12]. Ten thyroidectomized patients prior to their first radioiodine therapy with histologi-
cally confirmed advanced differentiated thyroid cancer were included. Patients were not in-
cluded if they had a medical history of salivary gland disease or affection, had received
external beam radiotherapy to the neck or head, were taking anticholinergic medication, or
had dental implants. Furthermore, patients bearing iodine-avid lymph node metastases near
the salivary glands or thyroid remnant tissue with high uptake were not included, to avoid
impairments in the absorbed dose calculations [13]. The standard patient preparation
before 124I administration has been described previously [14]. Thyroid-stimulating hormone
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before imaging were ≥25 mIU/mL. The mean ± standard deviation (SD) of the 124I
activity was 22.7 ± 1.0 MBq. The patients gave written informed consent to perform the
examination and the study was conducted in full accordance with regional ethical com-
mittee standard.
Chewing-gum stimulation protocol
During the first day, the patients were instructed to chew on tasteless gum base (Solsona;
Cafosa Gum S.A., Barcelona, Spain) approximately 20 min after capsule ingestion and to
drink water. The patients were instructed to continue gum chewing with a frequency of 3
to 4 gums per hour and to drink at least 2 L of water. The patients ate lunch after the first
4-h 124I PET/CT investigation and later ate a snack and dinner. The intake of sour foods
or drinks such as orange juice was avoided. The patients documented the time points of
gum and water intakes during the first day.
Salivary gland dosimetry protocol
The patients underwent a series of three 124I PET/CT scans on a Biograph Duo system
(Siemens Medical Solutions, Chicago, IL, USA). PET imaging was acquired at about 4, 24,
and ≥96 h after oral intake of a capsule containing [124I]NaI. The emission time was 300 s
per bed position. The low-dose CT acquisition parameters were as follows: tube current
time product of 15 mAs, tube voltage of 110 kVp, a pitch of 1.6, and a slice thickness of 5
mm. The emission images were reconstructed using the iterative attenuation-weighted
ordered-subset expectation maximization algorithm with 4 iterations and 16 subsets. A
post-reconstruction three-dimensional Gaussian smoothing filter of 5 mm was applied.
Standard scatter, attenuation, and dead-time corrections provided by the manufacturer
were used. The reconstructed transverse emission images had a voxel size of 1.7 × 1.7 ×
2.4 mm3. The measured reconstructed PET spatial resolution (expressed as full width at
half maximum) was 8.2 mm. The CT images were reconstructed using a reconstruction
interval of 2.4 mm; the reconstructed image had a voxel size of 1.0 × 1.0 × 2.4 mm3.
Patient analyses
The details of the patient analyses have been described in the literature [14]. The analyses
consisted of image co-registration, delineation of the salivary gland volume, applying
volume-dependent isovolume 124I recovery coefficients, and determination of the glandu-
lar residence times and absorbed doses per administered activity. Image co-registration
across time was performed by matching the reference 4-h CT image with the 24-h CT
image and the last CT image at ≥96 h. The resulting transformation parameters were
then applied to the respective PET image for each time point. The salivary gland volumes
were determined from the anatomical images by drawing a volume of interest around
each salivary gland. The individual volume of interest was projected onto the co-registered
PET image and used to determine the ratio of total activity to the gland volume; this ratio
is referred to as the (imaged) isovolume activity concentration. The isovolume activity
concentrations were then corrected for partial volume effect using isovolume 124I recovery
coefficients derived from measurements with a phantom containing spheres of different
volumes. It has been shown that the isovolume 124I recovery coefficients of spheres
matched well with spheroids mimicking salivary glands. Finally, the radioactive decay law
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projected 131I uptake values, U124(t) and U131(t) at the time point t, respectively, were
determined.
The absorbed doses per 131I activity were estimated using a three-point model con-
sisting of two contributions. The uptake curve was parameterized using a combination
of linear functions from 0 to 24 h (first contribution) and a mono-exponential function
from 24 h to infinity (second contribution). In the first part, trapezoid integration was
applied for the area under the curve from zero time, U131(0) = 0, to 24 h, U131(24 h).
The contribution resulting from the exponential phase was the time integral from 24 h
to infinity using an effective 131I half-life that was calculated from the uptake values
U131(24 h) and U131(≥96 h) by linear regression analysis. In the estimation of the glan-
dular absorbed dose per activity, the volume, the residence time (see above), and the
glandular tissue density were required. A density of 1.05 g/mL was used for the salivary
glands. A uniform activity distribution within the salivary gland was assumed.
In the previous studies [10,14], the estimation of the absorbed doses per activity for
the non-stimulation and lemon-juice stimulation groups was calculated using a seven-
point model. In particular, additional PET measurements were acquired at 0.5, 1, 2, and
48 h after 124I administration, which were taken into account in the estimation of the
residence time. The area under the uptake curve was determined by applying the trap-
ezoid integration rule with a truncation at the time point of the last PET scan (≥96 h).
To examine the effect of the reduced number of time points (three points vs. seven
points) and the different integration approaches (piecewise trapezoid-exponential inte-
gration vs. trapezoid integration), the glandular absorbed doses per activity for the non-
stimulation and lemon-juice stimulation groups were re-assessed using the three-point
model and compared to those of the seven-point model.
Statistical analysis
The descriptive statistics included the mean, the median, the SD, the minimum, and the
maximum, which are provided in the following form: mean (median) ± SD (minimum to
maximum). Differences among the groups were evaluated by the Mann-Whitney U test
(non-parametric test). The correlation between the different quantities was evaluated
using Spearman's rank correlation coefficient. A significance level (P value) of less than
5% was considered statistically significant.
Results
Blood flow measurements under three different stimulation types
The qualitative analysis of the glandular duplex sonograms of the three test persons showed
qualitatively different levels of blood perfusion within the glandular tissue (Figure 1). With
reference to the sonograms obtained from the non-stimulated salivary gland, the blood
perfusion was clearly increased under lemon-juice stimulation. In contrast, under chewing-
gum stimulation, the glandular tissue exhibited a slight increase, which was irrelevant
compared with the increase in level of blood perfusion under lemon-juice stimulation.
Patient and stimulation characteristics of the chewing-gum stimulation group
The patient characteristics of the chewing-gum stimulation group are given in Table 1.
In comparison with those of the non-stimulation and lemon-juice stimulation groups
Figure 1 Duplex sonograms of the salivary glands under different stimulation types. The sonograms
of a healthy person (male, 47 years) show relative changes in blood perfusion of the submandibular gland
induced by chewing-gum stimulation (a), non-stimulation (b), and lemon-juice stimulation (c). Blood flow
information is superimposed in colour onto the conventional anatomical gray-scale image. The thick white
lines within the thin white rectangles indicate the approximate glandular boundaries. The chewing-gum
stimulation, non-stimulation, and lemon-juice stimulation are designated by CS, NS, and LS, respectively.
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except for the age. The patients in the lemon-juice stimulation group (P = 0.03)
and the non-stimulation group (P = 0.10) were older, 51 (48) ± 14 years (31 to
73 years) and 48 (48) ± 18 years (22 to 72 years), respectively, than the patients in
the chewing-gum stimulation group, 35 (30) ± 14 years (21 to 64 years). This age
difference was a consequence of excluding patients with dental implants in this
study.
The statistics of the number of chewing gums that were taken during the course of
the first day were 6 (6) ± 2 (3 to 11) within the first 4-h interval (or before the first 124I
PET/CT acquisition) and 13 (12) ± 7 (6 to 25) till the end of the first day. The water
consumption ranged from 1.5 to 3 L with a mean (median) of 2.0 (2.0) L.Absorbed dose, glandular volume, and residence time of the salivary gland under
chewing-gum stimulation
Figure 2 illustrates, as an example, fused PET/CT images of the submandibular and
parotid glands with volumes of interest delineating the CT-based boundaries of the
salivary glands. Representative examples of the uptake curves of the salivary glands are
shown in Figure 3. The within-group statistical analysis revealed no statistically signifi-
cant difference in the absorbed doses between the submandibular and parotid glands
under chewing-gum stimulation (Table 2, P = 0.84). The mean ± SD absorbed doses to
the salivary glands per activity was 0.22 ± 0.09Gy/GBq. The statistics of the singleTable 1 Patient characteristics of the chewing-gum stimulation group
Characteristics Chewing-gum stimulation group
Started chewing gum basea Approximately 20 min
Number of patients 10
Age (years)b 35 (30) ± 14 (21 to 64)
Gender (male/female) 4/6
Weight (kg)b 76 (72) ± 15 (59 to 104)
Histology (papillary/follicular) 8/2
TSH stimulation (endogenous/exogenous)c 10/0
TSH (mIU/L)b 74 (68) ± 35 (36 to 150)
aAfter 124I administration. bMean (median) ± SD (range). cThyroid-stimulating hormone (TSH) stimulation was achieved by
hormone withdrawal (endogenous) or by injection of recombinant human TSH (exogenous).
Figure 2 Fused 124I PET/CT slice views of the salivary glands 4 h after 124I administration. Transverse slice
images of the submandibular (a) and parotid (b) glands with volumes of interest (indicated by white lines) are
shown. The grayscale (CT) and colour scale (PET) ranges were −125 to 225 HU and 0 to 2 kBq/mL, respectively.
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glands and 20.90 (19.42) ± 6.13 mL (12.73 to 32.54 mL) for the parotid glands. The
statistics for the residence time of the single submandibular and parotid glands were
1.10 (1.05) ± 0.40 min (0.51 to 2.08 min) and 2.35 (2.16) ± 1.07 min (1.20 to 4.70 min),
respectively. The difference in the mean residence time between the gland types was
attributed to the difference in gland volumes.
Of note, the relationship between absorbed doses per 131I activity and the number of
chewing gums yielded no correlations. Specifically, Spearman's rank correlation coeffi-
cients and P values (within parentheses) were −0.40 (0.02) for the number of chewing
gums within the 4-h interval, −0.20 (0.25) for the number of chewing gums after the first
PET/CT scan, and −0.24 (0.17) for the total number of gums chewed on the first day.
Absorbed dose comparison of the three different stimulation types
For all different stimulation groups, Table 2 juxtaposes the statistics of the absorbed doses
to the submandibular and parotid glands. Figure 4 illustrates the distribution of theFigure 3 Representative examples of the (projected) 131I uptake curve of the salivary gland. The measured
uptake values (symbols) of the submandibular (a) and parotid (b) glands are in percentage of administered
activity per kilogram of gland tissue. Solid lines indicate the fitted curves.
Table 2 Absorbed dose per activity (in Gy/GBq) for the submandibular and parotid
glands under different stimulations
Gland type Statistics Stimulation group
Chewing-gum Non-stimulationa Lemon-juicea
Submandibular gland Mean (median) 0.22 (0.22) 0.24 (0.22) 0.35 (0.29)
±SD (min to max) 0.09 (0.09 to 0.36) 0.08 (0.14 to 0.45) 0.14 (0.20 to 0.67)
Deviation (%)b −37 (0.04) −31 (0.09) Reference
Parotid gland Mean (median) 0.22 (0.20) 0.21 (0.19) 0.33 (0.32)
±SD (min to max) 0.08 (0.07 to 0.44) 0.05 (0.16 to 0.31) 0.09 (0.15 to 0.48)
Deviation (%)b −33 (<0.001) −36 (<0.001) Reference
aData were taken from reference [10] and used to re-assess the absorbed doses using the three-point model. bPercentage
deviation from the mean of the lemon-juice stimulation group (reference) and its significant difference level
(within parentheses).
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stimulation groups are shown to the right of the dashed horizontal lines in Figure 4; these
absorbed doses were re-assessed using the three-point model. The absorbed doses per ac-
tivity and the significant difference between non-stimulation and lemon-juice stimulation
were similar to the results that were obtained using the seven-point model [10]. For ex-
ample, the inter-group comparison revealed that the absorbed dose averaged over both
gland types (Figure 4a) was significantly reduced by 32% (P < 0.001) in the non-stimulation
group (0.23 Gy/GBq) compared with the lemon-juice stimulation group (0.34 Gy/GBq).
The respective values using the seven-point model were 28% for the percentage decrease
(P = 0.01) and 0.23 Gy/Gbq for the non-stimulation group and 0.32 Gy/GBq for the
lemon-juice stimulation group. Hence, in all of the subsequent sections, the results of theFigure 4 Distribution of the absorbed dose per administered activity for the different stimulation
types. The absorbed dose distributions averaged over both gland types (a) and separately for the submandibular
(b) and parotid glands (c) are shown. In the absorbed dose calculation, the 3-point model was used. The levels of
significance between the groups are characterized by P values. The chewing-gum stimulation, non-stimulation, and
lemon-juice stimulation groups are designated by CS, NS, and LS, respectively.
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groups and used for further analyses.
The inter-group comparison showed that the mean absorbed doses averaged over
both gland types in the chewing-gum stimulation group were reduced by approximately
35% (0.22 Gy/GBq) compared with those in the lemon-juice stimulation group; this
observed difference was statistically significant (P < 0.001, Figure 4a). The inter-group
comparison, however, yielded no significant difference in the absorbed doses between
the chewing-gum stimulation and non-stimulation groups (P = 0.99, Figure 4a). Separ-
ate inter-group comparisons for the parotid or submandibular glands exhibited a
significant difference in the absorbed doses between the chewing-gum and lemon-juice
stimulation groups for both the submandibular (P = 0.04, Figure 4b) and parotid glands
(P < 0.001, Figure 4c).
Discussion
Duplex sonography images were acquired for the submandibular glands under three dif-
ferent stimulation types (Figure 1). Using the non-stimulation images as reference, a
minor increase of blood flow was observed under chewing-gum stimulation but a notable
increase of the blood flow was seen under lemon-juice stimulation. The observed increase
of blood flow for the lemon-juice stimulation compared with the non-stimulation was in
agreement with the results of a study that used a similar methodology [11].
This finding allows the following conjecture: If the lemon-juice stimulation is actually
associated with an increase of the absorbed dose per activity primarily caused by an
increased glandular blood flow, the results of the sonography investigations suggest that
the absorbed doses should be lower for the non-stimulation and chewing-gum stimula-
tion groups. In addition, because Dawes and Macpherson [15] demonstrated that the
salivary flow was higher while chewing gum base than for non-stimulation, it is ex-
pected that the absorbed doses will be lower for the chewing-gum stimulation group
than for the non-stimulation and lemon-juice stimulation groups. Thus, the washout
effect may dominate over the rebound effect when chewing gum base. These sugges-
tions were partially confirmed in this study.
In line with the expectation, the comparison of the absorbed doses per activity
between the lemon-juice and chewing-gum stimulation groups yielded, on average, a
significantly lower value for the chewing-gum than for the lemon-juice stimulation
group (Table 2 and Figure 4). The absorbed dose per activity was approximately 30% to
40% lower when chewing tasteless gum. The above findings demonstrate that the
increased blood flow appears to be a decisive factor causing the increased absorbed
doses in the lemon-juice stimulation group. However, no significant difference in the
absorbed doses per activity (P ≥ 0.60) was observed between the chewing-gum stimula-
tion and non-stimulation groups (Figure 4); the percentage difference of the mean
absorbed dose was −8% for the submandibular gland and 5% for the parotid gland.
Contrary to the expectation, chewing-gum stimulation and non-stimulation yielded
similar absorbed doses per activity. Thus, the assumed washout effect was not large
enough to alter significantly the absorbed dose between the chewing-gum stimulation
and non-stimulation groups.
A reason for the statistically insignificant difference may be associated with a dimin-
ished washout effect by opposing changes. In detail, the non-stimulated salivary glands
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strated that continuous chewing on tasteless gum base increases the salivary flow rate
by a factor of approximately 3 (after 5 min) compared with the salivary flow rate at rest
[15]; however, a slight increase in glandular blood flow is also observed as demon-
strated by sonograms in this study. Hence, it appears that the efflux of radioiodine (in-
creased salivary flow) is, to some extent, compensated for by a simultaneous influx of
radioiodine (increased blood flow), which explains why the washout effect did not
overly dominate under chewing-gum stimulation.
In addition, stimulation protocol-related and methodological factors may influence the
outcome of the absorbed dose calculations. Variations of the number of chewing gums
per hour and of chewing frequency may affect the results. Dawes and Macpherson [15]
demonstrated that the flow rate ratio of initial to later chewing on gum base is approxi-
mately 5. Thus, the number of chewing gums on the first day influences the salivary flow
rate; however, no correlation between the number of chewing gums and the absorbed
doses per activity was observed in this study. Moreover, the salivary flow rate has been
demonstrated to be independent of the chewing frequency after a few minutes [16]. Meth-
odologically, the similar results of the absorbed doses using the three-point and seven-
point models show that the outcome is not strongly affected by the calculation models.
Moreover, the errors in the co-registration and the drawing of volumes of interest around
the salivary glands have been shown to produce an average error of 9% in the absorbed
dose calculation [17]. As a result, the factors mentioned are unlikely reasons for the unex-
pected findings.
Taken together, on the one hand, the use of chewing gums did not significantly
decrease the salivary gland absorbed dose in radioiodine therapy and is therefore not
helpful. Thus, the washout effect has not been proven, but neither can it be refuted. On
the other hand, lemon-juice stimulation also did not reduce the absorbed dose as dem-
onstrated by other studies [9,10]. The repeated use of lemon juice (every 15 to 20 min),
which has been proposed by van Nostrand et al. [7] to mitigate the salivary gland dam-
age, has not been proven to be favourable under clinical conditions and is possibly not
accepted by the patients. The results suggest that the salivary glands should not be
stimulated by either lemon juice or chewing gums.Conclusions
This study provided evidence, on the basis of 124I PET/CT imaging, that chewing-gum
stimulation immediately after 131I administration did not significantly decrease the
absorbed dose to the salivary glands in radioiodine therapy compared with the non-
stimulated salivary glands. We suggest that the increased glandular blood flow over-
compensates the washout effect in the lemon-juice stimulation group and, to a lesser
extent, also in the chewing-gum stimulation group.
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